<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="9" family="Frutiger-UltraBlack,Bold" color="#336fb7"/>
	<fontspec id="font1" size="9" family="Frutiger-UltraBlack,Bold" color="#007b83"/>
	<fontspec id="font2" size="9" family="Courier" color="#007b83"/>
	<fontspec id="font3" size="9" family="Frutiger-Light" color="#231f20"/>
	<fontspec id="font4" size="9" family="Arial" color="#000000"/>
	<fontspec id="font5" size="7" family="Arial,Italic" color="#000000"/>
	<fontspec id="font6" size="24" family="Frutiger-UltraBlack,Bold" color="#000000"/>
	<fontspec id="font7" size="11" family="Helvetica-Black,Bold" color="#ffffff"/>
	<fontspec id="font8" size="14" family="GillSans-Light" color="#000000"/>
	<fontspec id="font9" size="16" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font10" size="15" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font11" size="11" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font12" size="8" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font13" size="6" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font14" size="11" family="GillSans,Bold" color="#000000"/>
	<fontspec id="font15" size="11" family="GillSans" color="#000000"/>
	<fontspec id="font16" size="10" family="Giovanni-Book" color="#000000"/>
	<fontspec id="font17" size="8" family="GillSans" color="#000000"/>
	<fontspec id="font18" size="8" family="GillSans,Italic" color="#000000"/>
	<fontspec id="font19" size="8" family="GillSans,Bold" color="#000000"/>
<text top="44" left="508" width="16" height="9" font="font0" id="p1_t1" reading_order_no="1" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/"><b>Bio</b></a></text>
<text top="44" left="525" width="22" height="9" font="font1" id="p1_t2" reading_order_no="2" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/"><b>Med</b></a></text>
<text top="44" left="548" width="27" height="9" font="font3" id="p1_t3" reading_order_no="3" segment_no="1" tag_type="title"><a href="http://www.biomedcentral.com/">Central</a></text>
<text top="756" left="508" width="46" height="10" font="font4" id="p1_t4" reading_order_no="75" segment_no="21" tag_type="text">Page 1 of 6</text>
<text top="769" left="432" width="122" height="8" font="font5" id="p1_t5" reading_order_no="76" segment_no="22" tag_type="text"><i>(page number not for citation purposes)</i></text>
<text top="35" left="55" width="397" height="23" font="font6" id="p1_t6" reading_order_no="0" segment_no="0" tag_type="title"><b>Clinical and Molecular Allergy</b></text>
<text top="86" left="502" width="79" height="10" font="font7" id="p1_t7" reading_order_no="4" segment_no="2" tag_type="title"><a href="http://www.biomedcentral.com/info/about/charter/"><b>Open Access</b></a></text>
<text top="87" left="55" width="73" height="13" font="font8" id="p1_t8" reading_order_no="5" segment_no="3" tag_type="title">Commentary</text>
<text top="105" left="55" width="290" height="15" font="font9" id="p1_t9" reading_order_no="6" segment_no="4" tag_type="title"><b>Assessment of allergen cross-reactivity</b></text>
<text top="122" left="55" width="108" height="14" font="font10" id="p1_t10" reading_order_no="7" segment_no="5" tag_type="text">Rob C Aalberse*</text>
<text top="122" left="163" width="14" height="10" font="font11" id="p1_t11" reading_order_no="8" segment_no="5" tag_type="text">1,2</text>
<text top="158" left="55" width="31" height="8" font="font12" id="p1_t12" reading_order_no="9" segment_no="6" tag_type="text">Address: </text>
<text top="157" left="86" width="3" height="5" font="font13" id="p1_t13" reading_order_no="10" segment_no="6" tag_type="text">1</text>
<text top="158" left="89" width="465" height="8" font="font12" id="p1_t14" reading_order_no="11" segment_no="6" tag_type="text">Sanquin Research and Karl Landsteiner Laboratory, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands </text>
<text top="167" left="55" width="15" height="8" font="font12" id="p1_t15" reading_order_no="12" segment_no="6" tag_type="text">and </text>
<text top="167" left="70" width="3" height="5" font="font13" id="p1_t16" reading_order_no="13" segment_no="6" tag_type="text">2</text>
<text top="167" left="74" width="400" height="8" font="font12" id="p1_t17" reading_order_no="14" segment_no="6" tag_type="text">Department of Immunopathology, Sanquin Research, Plesmanlaan 125, NL, 1066 CX Amsterdam, The Netherlands</text>
<text top="182" left="55" width="166" height="8" font="font12" id="p1_t18" reading_order_no="15" segment_no="7" tag_type="text">Email: Rob C Aalberse* - r.aalberse@sanquin.nl</text>
<text top="193" left="55" width="92" height="8" font="font12" id="p1_t19" reading_order_no="16" segment_no="8" tag_type="text">* Corresponding author    </text>
<text top="341" left="112" width="44" height="10" font="font14" id="p1_t20" reading_order_no="29" segment_no="16" tag_type="title"><b>Abstract</b></text>
<text top="355" left="112" width="385" height="10" font="font15" id="p1_t21" reading_order_no="30" segment_no="17" tag_type="text">The prediction of allergen cross-reactivity is currently largely based on linear sequence</text>
<text top="367" left="112" width="386" height="10" font="font15" id="p1_t22" reading_order_no="31" segment_no="17" tag_type="text">data, but will soon include 3D information on homology among surface exposed</text>
<text top="379" left="112" width="386" height="10" font="font15" id="p1_t23" reading_order_no="32" segment_no="17" tag_type="text">residues. To evaluate procedures for these predictions, we need ways to quantitatively</text>
<text top="391" left="112" width="386" height="10" font="font15" id="p1_t24" reading_order_no="33" segment_no="17" tag_type="text">assess actual cross-reactivity between two allergens. Three parameters are mentioned:</text>
<text top="402" left="112" width="386" height="10" font="font15" id="p1_t25" reading_order_no="34" segment_no="17" tag_type="text">1) the fraction of the epitopes that is cross-reactive; 2) the fraction of IgE that is cross-</text>
<text top="414" left="112" width="386" height="10" font="font15" id="p1_t26" reading_order_no="35" segment_no="17" tag_type="text">reactive; 3) the relative affinity of the interaction between IgE and the two allergens.</text>
<text top="426" left="112" width="386" height="10" font="font15" id="p1_t27" reading_order_no="36" segment_no="17" tag_type="text">This editorial briefly compares direct binding protocols with the often more</text>
<text top="438" left="112" width="385" height="10" font="font15" id="p1_t28" reading_order_no="37" segment_no="17" tag_type="text">appropriate reciprocal inhibition protocols. The latter type of protocol provides</text>
<text top="449" left="112" width="386" height="10" font="font15" id="p1_t29" reading_order_no="38" segment_no="17" tag_type="text">information on symmetric versus asymmetric cross-reactivity, and thus on the</text>
<text top="461" left="112" width="386" height="10" font="font15" id="p1_t30" reading_order_no="39" segment_no="17" tag_type="text">distinction between complete (= sensitising) allergens versus incomplete, cross-reacting</text>
<text top="473" left="112" width="385" height="10" font="font15" id="p1_t31" reading_order_no="40" segment_no="17" tag_type="text">allergens. The need to define the affinity threshold of the assay and a caveat on the use</text>
<text top="485" left="112" width="152" height="10" font="font15" id="p1_t32" reading_order_no="41" segment_no="17" tag_type="text">of serum pools are also discussed.</text>
<text top="535" left="55" width="241" height="9" font="font16" id="p1_t33" reading_order_no="42" segment_no="18" tag_type="text">In a paper recently published in this Journal, the question</text>
<text top="546" left="55" width="241" height="9" font="font16" id="p1_t34" reading_order_no="43" segment_no="18" tag_type="text">was raised whether a fungus considered for biological pest</text>
<text top="558" left="55" width="241" height="9" font="font16" id="p1_t35" reading_order_no="44" segment_no="18" tag_type="text">control (Beauvaria bassiana) could elicit allergic reactions</text>
<text top="570" left="55" width="241" height="9" font="font16" id="p1_t36" reading_order_no="45" segment_no="18" tag_type="text">due to cross-reactive IgE antibodies induced by allergens</text>
<text top="581" left="55" width="241" height="9" font="font16" id="p1_t37" reading_order_no="46" segment_no="18" tag_type="text">from known allergen<a href="">ic fungi [1</a>]. Based on homology in</text>
<text top="593" left="55" width="241" height="9" font="font16" id="p1_t38" reading_order_no="47" segment_no="18" tag_type="text">the amino acid sequence, four potentially cross-reactive</text>
<text top="605" left="55" width="241" height="9" font="font16" id="p1_t39" reading_order_no="48" segment_no="18" tag_type="text">proteins were cloned, expressed in E coli and tested for IgE</text>
<text top="617" left="55" width="241" height="9" font="font16" id="p1_t40" reading_order_no="49" segment_no="18" tag_type="text">(cross)reactivity using sera from patients with known fun-</text>
<text top="629" left="55" width="241" height="9" font="font16" id="p1_t41" reading_order_no="50" segment_no="18" tag_type="text">gal allergies. Support for (cross)reactivity was found for</text>
<text top="640" left="55" width="241" height="9" font="font16" id="p1_t42" reading_order_no="51" segment_no="18" tag_type="text">two of these four proteins. The two (cross)reactive pro-</text>
<text top="652" left="55" width="241" height="9" font="font16" id="p1_t43" reading_order_no="52" segment_no="18" tag_type="text">teins had the highest sequence homology to known aller-</text>
<text top="664" left="55" width="241" height="9" font="font16" id="p1_t44" reading_order_no="53" segment_no="18" tag_type="text">gens: the enolase was 85% sequence-identical to the</text>
<text top="676" left="55" width="241" height="9" font="font16" id="p1_t45" reading_order_no="54" segment_no="18" tag_type="text">Alternaria enolase known as Alt a 6 and the aldehyde</text>
<text top="687" left="55" width="241" height="9" font="font16" id="p1_t46" reading_order_no="55" segment_no="18" tag_type="text">dehydrogenase was 71% sequence-identical to the Alter-</text>
<text top="699" left="55" width="241" height="9" font="font16" id="p1_t47" reading_order_no="56" segment_no="18" tag_type="text">naria dehydrogenase Alt a 10. The two proteins with no</text>
<text top="711" left="55" width="241" height="9" font="font16" id="p1_t48" reading_order_no="57" segment_no="18" tag_type="text">demonstrable (cross)reactivity had sequence identities of</text>
<text top="722" left="55" width="241" height="9" font="font16" id="p1_t49" reading_order_no="58" segment_no="18" tag_type="text">51 and 60% to two Aspergillus fumigatus proteins. It is</text>
<text top="535" left="313" width="241" height="9" font="font16" id="p1_t50" reading_order_no="59" segment_no="19" tag_type="text">tempting to conclude that this result supports the notion</text>
<text top="546" left="313" width="241" height="9" font="font16" id="p1_t51" reading_order_no="60" segment_no="19" tag_type="text">that sequence identity is a useful predictor of cross-reactiv-</text>
<text top="558" left="313" width="13" height="9" font="font16" id="p1_t52" reading_order_no="61" segment_no="19" tag_type="text">ity.</text>
<text top="581" left="313" width="241" height="9" font="font16" id="p1_t53" reading_order_no="62" segment_no="20" tag_type="text">A few comments on the prediction on cross-reactivity as</text>
<text top="593" left="313" width="241" height="9" font="font16" id="p1_t54" reading_order_no="63" segment_no="20" tag_type="text">illustrated by this study. As the authors point out, the</text>
<text top="605" left="313" width="241" height="9" font="font16" id="p1_t55" reading_order_no="64" segment_no="20" tag_type="text">number of sera used to test for cross-reactivity was small</text>
<text top="617" left="313" width="241" height="9" font="font16" id="p1_t56" reading_order_no="65" segment_no="20" tag_type="text">(N = 20, tested as 10 pools of 2; a caveat on the use of</text>
<text top="629" left="313" width="241" height="9" font="font16" id="p1_t57" reading_order_no="66" segment_no="20" tag_type="text">serum pools will be discussed later). Moreover, the clini-</text>
<text top="640" left="313" width="241" height="9" font="font16" id="p1_t58" reading_order_no="67" segment_no="20" tag_type="text">cal history of the patients is not specified, which is partic-</text>
<text top="652" left="313" width="241" height="9" font="font16" id="p1_t59" reading_order_no="68" segment_no="20" tag_type="text">ularly relevant in view of the quite distinct modes of</text>
<text top="664" left="313" width="241" height="9" font="font16" id="p1_t60" reading_order_no="69" segment_no="20" tag_type="text">allergen exposure in case of invasive aspergillosis as com-</text>
<text top="676" left="313" width="241" height="9" font="font16" id="p1_t61" reading_order_no="70" segment_no="20" tag_type="text">pared to airborne Alternaria. IgE reactivity was investi-</text>
<text top="687" left="313" width="241" height="9" font="font16" id="p1_t62" reading_order_no="71" segment_no="20" tag_type="text">gated by immunoblotting of crude E. coli extracts as the</text>
<text top="699" left="313" width="241" height="9" font="font16" id="p1_t63" reading_order_no="72" segment_no="20" tag_type="text">source of the recombinant proteins, which is useful but</text>
<text top="711" left="313" width="241" height="9" font="font16" id="p1_t64" reading_order_no="73" segment_no="20" tag_type="text">not ideal since it is known to be inefficient for some aller-</text>
<text top="722" left="313" width="241" height="9" font="font16" id="p1_t65" reading_order_no="74" segment_no="20" tag_type="text">gens. Lastly, as discussed in more detail below, cross-reac-</text>
<text top="236" left="55" width="88" height="7" font="font17" id="p1_t66" reading_order_no="17" segment_no="9" tag_type="text">Published: 9 February 2007</text>
<text top="250" left="55" width="88" height="7" font="font18" id="p1_t67" reading_order_no="18" segment_no="12" tag_type="text"><i>Clinical and Molecular Allergy</i></text>
<text top="250" left="143" width="22" height="7" font="font17" id="p1_t68" reading_order_no="19" segment_no="12" tag_type="text"> 2007, </text>
<text top="250" left="165" width="4" height="7" font="font19" id="p1_t69" reading_order_no="20" segment_no="12" tag_type="text"><b>5</b></text>
<text top="250" left="170" width="6" height="7" font="font17" id="p1_t70" reading_order_no="21" segment_no="12" tag_type="text">:2</text>
<text top="250" left="185" width="88" height="7" font="font17" id="p1_t71" reading_order_no="22" segment_no="12" tag_type="text">doi:10.1186/1476-7961-5-2</text>
<text top="236" left="310" width="85" height="7" font="font17" id="p1_t72" reading_order_no="27" segment_no="10" tag_type="text">Received: 23 January 2007</text>
<text top="245" left="310" width="88" height="7" font="font17" id="p1_t73" reading_order_no="28" segment_no="11" tag_type="text">Accepted: 9 February 2007</text>
<text top="264" left="55" width="269" height="7" font="font17" id="p1_t74" reading_order_no="23" segment_no="13" tag_type="text"><a href="http://www.clinicalmolecularallergy.com/content/5/1/2">This article is available from: http://www.clinicalmolecularallergy.com/content/5/1/2</a></text>
<text top="279" left="55" width="155" height="7" font="font17" id="p1_t75" reading_order_no="24" segment_no="14" tag_type="text">© 2007 Aalberse; licensee BioMed Central Ltd. </text>
<text top="288" left="55" width="492" height="7" font="font17" id="p1_t76" reading_order_no="25" segment_no="15" tag_type="text">This is an Open Access article distributed under the terms of the Creative Commons Attribution Licens<a href="http://creativecommons.org/licenses/by/2.0">e (http://creativecommons.org/licenses/by/2.0), </a></text>
<text top="297" left="55" width="400" height="7" font="font17" id="p1_t77" reading_order_no="26" segment_no="15" tag_type="text">which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</text>
</page>
</pdf2xml>
